Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07256704 HYPNOVA — Hypnosis and Attention in Patients With a Neurological Diseas… |
HYPNOVA — Hypnosis and Attention … | SEP | Non applicable | RECRUITING | En attente / non publié | Luzerner Kantonsspital | Switzerland · Luzerner Kantonsspital, Lucerne, Switze… | 2025-11-18 → 2029-07-31 | Ouvrir |
| NCT05958381 MS-HDtDCS — Treatment of Cognitive Deficits in Multiple Sclerosis With … |
Transcranial Direct Current stimu… | SEP | Non applicable | RECRUITING | En attente / non publié | Dr. Ram Manohar Lohia Hospital | United States · The University of Texas at Dallas, Ri… | 2023-10-18 → 2027-06-29 | Ouvrir |
| NCT07766213 Pain Phenotypes in Individuals With Multiple Sclerosis |
Pain Phenotypes in Individuals Wi… | SEP | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Kutahya Health Sciences University | Turkey (Türkiye) · Kutahya Health Sciences University… | 2026-08-15 → 2027-09-15 | Ouvrir |
| NCT07765212 INDAMS — Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Pro… |
Indapamide | SEP | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Eva M.M. Strijbis | Non communiqué | 2026-09 → 2028-09 | Ouvrir |
| NCT07325292 Frexcite — Non-inferiority Study of Frexalimab Subcutaneous Administrat… |
Frexalimab | SEP | Phase 3 | RECRUITING | En attente / non publié | Sanofi | United States, Belgium, China, Italy, Japan · Advance… | 2026-01-14 → 2028-11-30 | Ouvrir |
| NCT03437473 Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumato… |
SetPoint Medical Neurostimulation… | SEP | Non applicable | COMPLETED | En attente / non publié | SetPoint Medical Corporation | United States · Altoona Center for Clinical Research,… | 2018-03-06 → 2018-12-10 | Ouvrir |
| NCT07489326 ACTIVATE — The SetPoint System Safety & Performance Post-Approval Study |
SetPoint System | SEP | À vérifier | NOT_YET_RECRUITING | En attente / non publié | SetPoint Medical Corporation | Non communiqué | 2026-04-15 → 2031-01-01 | Ouvrir |
| NCT04862117 Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in… |
SetPoint Medical Neurostimulation… | SEP | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | SetPoint Medical Corporation | United States · Altoona Center for Clinical Research,… | 2018-07-28 → 2026-12-08 | Ouvrir |
| NCT04539964 RESET-RA — Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Ar… |
Implant Procedure | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | SetPoint Medical Corporation | United States · Albuquerque Center For Rheumatology, … | 2021-01-11 → 2027-10 | Ouvrir |
| NCT07650019 EDA-Based Adaptive Support in VR ALS Training |
EDA-Based Adaptive Support in VR … | Sclérose latérale amyotrophique | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Acibadem University | Non communiqué | 2026-07 → 2026-07 | Ouvrir |
| NCT07239531 Combined Interval Training and Scenario Simulation for ALS Training of … |
Combined Interval Training and Sc… | Sclérose latérale amyotrophique | Non applicable | NOT_YET_RECRUITING | En attente / non publié | General Hospital of Ningxia Medic… | China · General Hospital of Ningxia Medical Universit… | 2026-09-01 → 2027-02-28 | Ouvrir |
| NCT02795052 NEST — Neurologic Stem Cell Treatment Study |
Intravenous and Intranasal BMSC | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | MD Stem Cells | United States, United Arab Emirates · MD Stem Cells, … | 2016-06 → 2028-07-31 | Ouvrir |
| NCT07071935 A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis … |
Non-invasive ventilation | Sclérose latérale amyotrophique | Phase 2 | RECRUITING | En attente / non publié | University of Pennsylvania | United States · Penn Comprehensive ALS Center at Penn… | 2026-06-11 → 2029-05 | Ouvrir |
| NCT04889898 Remote Speech and Swallowing Assessment in ALS |
Digital recording of speech and s… | Sclérose latérale amyotrophique | À vérifier | COMPLETED | En attente / non publié | Milton S. Hershey Medical Center | United States · Hershey Medical Center ALS Clinic, He… | 2022-01-01 → 2026-06-25 | Ouvrir |
| NCT06315673 Digital Assessment of Speech and Fine Motor Control in ALS |
Digital Assessment of Speech and … | Sclérose latérale amyotrophique | À vérifier | COMPLETED | En attente / non publié | Milton S. Hershey Medical Center | United States · Milton S. Hershey Medical Center, Her… | 2024-07-01 → 2026-06-01 | Ouvrir |
| NCT06051123 Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal D… |
Effects of Probiotics in Amyotrop… | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Centre hospitalier de l'Universit… | Canada · Centre Hospitalier de l'Universite de Montre… | 2024-01-01 → 2027-02 | Ouvrir |
| NCT04259255 Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) |
Edaravone (Radicava®/Radicava ORS… | Sclérose latérale amyotrophique | À vérifier | COMPLETED | En attente / non publié | Shionogi | United States, Canada · Barrow Neurological Institute… | 2019-10-21 → 2024-11-24 | Ouvrir |
| NCT07290062 ARMOR — A Study to Investigate the Safety and Pharmacodynamics of a Sin… |
INS1202 | Sclérose latérale amyotrophique | Phase 1 | RECRUITING | En attente / non publié | Insmed Gene Therapy LLC | United States · USA001, Columbia, United States | USA… | 2026-01-09 → 2030-03-31 | Ouvrir |
| NCT06643481 ASTRALS — A Clinical Trial to Learn About the Effects of VHB937 in Peop… |
VHB937 | Sclérose latérale amyotrophique | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Australia, Belgium, Canada, China, Den… | 2024-10-17 → 2028-07-10 | Ouvrir |
| NCT07213440 PremodiALS — Identification of Early Markers for ALS |
Lumbar Puncture | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Institut National de la Santé Et … | France · CHU Tours, Tours, France | 2024-09-30 → 2027-04 | Ouvrir |
| NCT07688239 The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Act… |
Foralumab Nasal | Sclérose latérale amyotrophique | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Tiziana Life Sciences LTD | Non communiqué | 2026-07-25 → 2027-11 | Ouvrir |
| NCT05067179 Analysis of Human ALS Tissues and Registry of ALS Patients |
Analysis of Human ALS Tissues and… | Sclérose latérale amyotrophique | À vérifier | RECRUITING | En attente / non publié | University of Illinois at Chicago | United States · University of Illinois at Chicago, Ch… | 2020-09-01 → 2030-01-01 | Ouvrir |
| NCT07698496 SpeechBCI — Evaluation of the Feasibility and Efficacy of a Chronic Bra… |
Chronic speech BCI | Sclérose latérale amyotrophique | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University Hospital, Grenoble | France · Centre hospitalier Grenoble, Grenoble, Franc… | 2026-10-10 → 2031-09-30 | Ouvrir |
| NCT07193953 ALSFUS003 — Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier D… |
Next Generation Dome Helmet Focus… | Sclérose latérale amyotrophique | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Sunnybrook Health Sciences Centre | Canada · Sunnybrook Health Sciences Centre, Toronto, … | 2025-04-15 → 2027-05-30 | Ouvrir |
| NCT04176224 Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrop… |
MT-1186 | Sclérose latérale amyotrophique | Phase 1 | COMPLETED | En attente / non publié | Shionogi | Japan · Investigational site, Tokyo, Japan | 2019-04-17 → 2019-09-04 | Ouvrir |